Kristian Wende, Clemens Mügge, Kerstin Thurow, Thomas Schöpke, Ulrike Lindequist: Actaeaepoxide 3-O-β-D-Xylopyranoside, a New Cycloartane Glycoside from the Rhizomes of Actaea racemosa (Cimicifuga racemosa). In: Journal of Natural Products. Band64, Nr.7, 1. Juli 2001, ISSN0163-3864, S.986–989, doi:10.1021/np000619e (acs.org).
ars-grin.gov
npgsweb.ars-grin.gov
Actaearacemosa im Germplasm Resources Information Network (GRIN), USDA, ARS, National Genetic Resources Program. National Germplasm Resources Laboratory, Beltsville, Maryland. Abgerufen am 22. Januar 2016.
Kristian Wende, Clemens Mügge, Kerstin Thurow, Thomas Schöpke, Ulrike Lindequist: Actaeaepoxide 3-O-β-D-Xylopyranoside, a New Cycloartane Glycoside from the Rhizomes of Actaea racemosa (Cimicifuga racemosa). In: Journal of Natural Products. Band64, Nr.7, 1. Juli 2001, ISSN0163-3864, S.986–989, doi:10.1021/np000619e (acs.org).
Hussein Al-Amier et al.: Evaluation of Extraction Methods for Isolation and Detection of Formononetin in Black Cohosh (Actaea racemosa L.). Journal of Medicinally Active Plants (1):6-12. doi:10.7275/R5CR5R84
E.J. Kennelly, S. Baggett, P. Nuntanakorn, A.L. Ososki, S.A. Mori: Analysis of thirteen populations of Black Cohosh for formononetin. In: Phytomedicine. Band9, Nr.5, Januar 2002, S.461–467, doi:10.1078/09447110260571733 (elsevier.com).
Heidi Fritz et al.: Black cohosh and breast cancer: A systematic review. Integr Cancer Ther. 2014 Jan;13(1):12-29. doi:10.1177/1534735413477191
Marcela Garita-Hernandez et al.: The growth inhibitory activity of the Cimicifuga racemosa extract Ze 450 is mediated through estrogen and progesterone receptors-independent pathways. Planta Med. 2006 Mar;72(4):317-23. doi:10.1055/s-2005-916233
F. Borrelli et al.: Pharmacological effects of Cimicifuga racemosa. Life Sci. 2003 Jul 25;73(10):1215-29. doi:10.1016/s0024-3205(03)00378-3
Hans-Heinrich Henneicke-von Zepelin: 60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development. In: Wiener Medizinische Wochenschrift. Band167, Nr.7-8, Mai 2017, ISSN0043-5341, S.147–159, doi:10.1007/s10354-016-0537-z, PMID 28155126, PMC 5409920 (freier Volltext) – (springer.com).
Petra Stute, Stefan Ehrentraut, Hans-Heinrich Henneicke-von Zepelin, Petra Nicken: Gene expression analyses on multi-target mode of action of black cohosh in menopausal complaints – a pilot study in rodents. In: Archives of Gynecology and Obstetrics. 14. Juli 2021, ISSN0932-0067, doi:10.1007/s00404-021-06105-8 (springer.com).
M. J. Leach, V. Moore: Black cohosh (Cimicifuga spp.) for menopausal symptoms. In: The Cochrane database of systematic reviews. Band 9, 2012, S. CD007244, doi:10.1002/14651858.CD007244.pub2, PMID 22972105 (Review).
André-M. Beer, Rüdiger Osmers, Jörg Schnitker, Wenpei Bai, Alfred O. Mueck: Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms – comments on major statements of the Cochrane Collaboration report 2012 “black cohosh (Cimicifuga spp.) for menopausal symptoms (review)”. In: Gynecological Endocrinology. Band29, Nr.12, Dezember 2013, ISSN0951-3590, S.1022–1025, doi:10.3109/09513590.2013.831836 (tandfonline.com).
C. Castelo-Branco, M. Gambacciani, A. Cano, M. J. Minkin, D. Rachoń: Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence. In: Climacteric. Band24, Nr.2, 4. März 2021, ISSN1369-7137, S.109–119, doi:10.1080/13697137.2020.1820477 (tandfonline.com).
André-Michael Beer, Albert Neff: Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints. Evidence-based Complementary and Alternative Medicine 2013(3):860602. doi:10.1155/2013/860602
Lena Friederichsen et al.: Effect of CIMicifuga racemosa on metaBOLIC parameters in women with menopausal symptoms: A retrospective observational study (CIMBOLIC). Archives of Gynecology and Obstetrics, Ausgabe 2/2020. doi:10.1007/s00404-019-05366-8
C. Moser et al.: Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice. Phytomedicine
Volume 21, Issue 11, 25. September 2014, S. 1382–1389. doi:10.1016/j.phymed.2014.06.002
X. Ruan, A. O. Mueck, A.-M. Beer, B. Naser, S. Pickartz: Benefit–risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St John’s wort in breast cancer patients. In: Climacteric. Band22, Nr.4, 4. Juli 2019, ISSN1369-7137, S.339–347, doi:10.1080/13697137.2018.1551346, PMID 30626212.
H.H. Henneicke-von Zepelin, H. Meden, K. Kostev, D. Schröder-Bernhardi, U. Stammwitz: Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. In: Int. Journal of Clinical Pharmacology and Therapeutics. Band45, Nr.03, 1. März 2007, ISSN0946-1965, S.143–154, doi:10.5414/CPP45143 (dustri.com).
Rolf Teschke, Wolfgang Schmidt-Taenzer, Albrecht Wolff: Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?: ASSUMED HERBAL HEPATOTOXICITY. In: Pharmacoepidemiology and Drug Safety. Band20, Nr.6, Juni 2011, S.567–582, doi:10.1002/pds.2127 (wiley.com).
Rolf Teschke: Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. In: Menopause. Band17, Nr.2, März 2010, ISSN1072-3714, S.426–440, doi:10.1097/gme.0b013e3181c5159c (lww.com).
Belal Naser, Jörg Schnitker, Mary Jane Minkin, Susana Garcia de Arriba, Klaus-Ulrich Nolte: Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. In: Menopause. Band18, Nr.4, April 2011, ISSN1072-3714, S.366–375, doi:10.1097/gme.0b013e3181fcb2a6 (lww.com).
Grace Guzman, Eric R. Kallwitz, Christina Wojewoda, Rohini Chennuri, Jamie Berkes, Thomas J. Layden, Scott J. Cotler: Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh. In: Case Reports in Medicine. Band2009, Article ID 918156, 2009, S.1–8, doi:10.1155/2009/918156, PMID 20130783, PMC 2814377 (freier Volltext).
Vittorio Unfer, Maria Luisa Casini, Loredana Costabile, Marcella Mignosa, Sandro Gerli: Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. In: Fertility and Sterility. Band82, Nr.1, Juli 2004, S.145–148, doi:10.1016/j.fertnstert.2003.11.041 (elsevier.com [abgerufen am 21. September 2021]).
Karel Rauš, Cosima Brucker, Christoph Gorkow, Wolfgang Wuttke: First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. In: Menopause. Band13, Nr.4, Juli 2006, ISSN1072-3714, S.678–691, doi:10.1097/01.gme.0000196813.34247.e2 (lww.com).
dustri.com
H.H. Henneicke-von Zepelin, H. Meden, K. Kostev, D. Schröder-Bernhardi, U. Stammwitz: Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. In: Int. Journal of Clinical Pharmacology and Therapeutics. Band45, Nr.03, 1. März 2007, ISSN0946-1965, S.143–154, doi:10.5414/CPP45143 (dustri.com).
efloras.org
Gwynn W. Ramsey: Cimicifuga. In: Flora of North America Editorial Committee (Hrsg.): Flora of North America North of Mexico. Volume 3: Magnoliophyta: Magnoliidae and Hamamelidae. Oxford University Press, New York / Oxford u. a. 1997, ISBN 0-19-511246-6, S.178 (englisch)., Cimicifuga racemosa textgleich online wie gedrucktes Werk.
elsevier.com
linkinghub.elsevier.com
E.J. Kennelly, S. Baggett, P. Nuntanakorn, A.L. Ososki, S.A. Mori: Analysis of thirteen populations of Black Cohosh for formononetin. In: Phytomedicine. Band9, Nr.5, Januar 2002, S.461–467, doi:10.1078/09447110260571733 (elsevier.com).
Vittorio Unfer, Maria Luisa Casini, Loredana Costabile, Marcella Mignosa, Sandro Gerli: Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. In: Fertility and Sterility. Band82, Nr.1, Juli 2004, S.145–148, doi:10.1016/j.fertnstert.2003.11.041 (elsevier.com [abgerufen am 21. September 2021]).
Rolf Teschke: Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. In: Menopause. Band17, Nr.2, März 2010, ISSN1072-3714, S.426–440, doi:10.1097/gme.0b013e3181c5159c (lww.com).
Belal Naser, Jörg Schnitker, Mary Jane Minkin, Susana Garcia de Arriba, Klaus-Ulrich Nolte: Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. In: Menopause. Band18, Nr.4, April 2011, ISSN1072-3714, S.366–375, doi:10.1097/gme.0b013e3181fcb2a6 (lww.com).
Karel Rauš, Cosima Brucker, Christoph Gorkow, Wolfgang Wuttke: First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. In: Menopause. Band13, Nr.4, Juli 2006, ISSN1072-3714, S.678–691, doi:10.1097/01.gme.0000196813.34247.e2 (lww.com).
nih.gov
ncbi.nlm.nih.gov
Hans-Heinrich Henneicke-von Zepelin: 60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development. In: Wiener Medizinische Wochenschrift. Band167, Nr.7-8, Mai 2017, ISSN0043-5341, S.147–159, doi:10.1007/s10354-016-0537-z, PMID 28155126, PMC 5409920 (freier Volltext) – (springer.com).
M. J. Leach, V. Moore: Black cohosh (Cimicifuga spp.) for menopausal symptoms. In: The Cochrane database of systematic reviews. Band 9, 2012, S. CD007244, doi:10.1002/14651858.CD007244.pub2, PMID 22972105 (Review).
X. Ruan, A. O. Mueck, A.-M. Beer, B. Naser, S. Pickartz: Benefit–risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St John’s wort in breast cancer patients. In: Climacteric. Band22, Nr.4, 4. Juli 2019, ISSN1369-7137, S.339–347, doi:10.1080/13697137.2018.1551346, PMID 30626212.
Grace Guzman, Eric R. Kallwitz, Christina Wojewoda, Rohini Chennuri, Jamie Berkes, Thomas J. Layden, Scott J. Cotler: Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh. In: Case Reports in Medicine. Band2009, Article ID 918156, 2009, S.1–8, doi:10.1155/2009/918156, PMID 20130783, PMC 2814377 (freier Volltext).
Hans-Heinrich Henneicke-von Zepelin: 60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development. In: Wiener Medizinische Wochenschrift. Band167, Nr.7-8, Mai 2017, ISSN0043-5341, S.147–159, doi:10.1007/s10354-016-0537-z, PMID 28155126, PMC 5409920 (freier Volltext) – (springer.com).
Petra Stute, Stefan Ehrentraut, Hans-Heinrich Henneicke-von Zepelin, Petra Nicken: Gene expression analyses on multi-target mode of action of black cohosh in menopausal complaints – a pilot study in rodents. In: Archives of Gynecology and Obstetrics. 14. Juli 2021, ISSN0932-0067, doi:10.1007/s00404-021-06105-8 (springer.com).
tandfonline.com
André-M. Beer, Rüdiger Osmers, Jörg Schnitker, Wenpei Bai, Alfred O. Mueck: Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms – comments on major statements of the Cochrane Collaboration report 2012 “black cohosh (Cimicifuga spp.) for menopausal symptoms (review)”. In: Gynecological Endocrinology. Band29, Nr.12, Dezember 2013, ISSN0951-3590, S.1022–1025, doi:10.3109/09513590.2013.831836 (tandfonline.com).
C. Castelo-Branco, M. Gambacciani, A. Cano, M. J. Minkin, D. Rachoń: Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence. In: Climacteric. Band24, Nr.2, 4. März 2021, ISSN1369-7137, S.109–119, doi:10.1080/13697137.2020.1820477 (tandfonline.com).
Rolf Teschke, Wolfgang Schmidt-Taenzer, Albrecht Wolff: Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?: ASSUMED HERBAL HEPATOTOXICITY. In: Pharmacoepidemiology and Drug Safety. Band20, Nr.6, Juni 2011, S.567–582, doi:10.1002/pds.2127 (wiley.com).
zdb-katalog.de
Kristian Wende, Clemens Mügge, Kerstin Thurow, Thomas Schöpke, Ulrike Lindequist: Actaeaepoxide 3-O-β-D-Xylopyranoside, a New Cycloartane Glycoside from the Rhizomes of Actaea racemosa (Cimicifuga racemosa). In: Journal of Natural Products. Band64, Nr.7, 1. Juli 2001, ISSN0163-3864, S.986–989, doi:10.1021/np000619e (acs.org).
Hans-Heinrich Henneicke-von Zepelin: 60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development. In: Wiener Medizinische Wochenschrift. Band167, Nr.7-8, Mai 2017, ISSN0043-5341, S.147–159, doi:10.1007/s10354-016-0537-z, PMID 28155126, PMC 5409920 (freier Volltext) – (springer.com).
Petra Stute, Stefan Ehrentraut, Hans-Heinrich Henneicke-von Zepelin, Petra Nicken: Gene expression analyses on multi-target mode of action of black cohosh in menopausal complaints – a pilot study in rodents. In: Archives of Gynecology and Obstetrics. 14. Juli 2021, ISSN0932-0067, doi:10.1007/s00404-021-06105-8 (springer.com).
André-M. Beer, Rüdiger Osmers, Jörg Schnitker, Wenpei Bai, Alfred O. Mueck: Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms – comments on major statements of the Cochrane Collaboration report 2012 “black cohosh (Cimicifuga spp.) for menopausal symptoms (review)”. In: Gynecological Endocrinology. Band29, Nr.12, Dezember 2013, ISSN0951-3590, S.1022–1025, doi:10.3109/09513590.2013.831836 (tandfonline.com).
C. Castelo-Branco, M. Gambacciani, A. Cano, M. J. Minkin, D. Rachoń: Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence. In: Climacteric. Band24, Nr.2, 4. März 2021, ISSN1369-7137, S.109–119, doi:10.1080/13697137.2020.1820477 (tandfonline.com).
X. Ruan, A. O. Mueck, A.-M. Beer, B. Naser, S. Pickartz: Benefit–risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St John’s wort in breast cancer patients. In: Climacteric. Band22, Nr.4, 4. Juli 2019, ISSN1369-7137, S.339–347, doi:10.1080/13697137.2018.1551346, PMID 30626212.
H.H. Henneicke-von Zepelin, H. Meden, K. Kostev, D. Schröder-Bernhardi, U. Stammwitz: Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. In: Int. Journal of Clinical Pharmacology and Therapeutics. Band45, Nr.03, 1. März 2007, ISSN0946-1965, S.143–154, doi:10.5414/CPP45143 (dustri.com).
Rolf Teschke: Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. In: Menopause. Band17, Nr.2, März 2010, ISSN1072-3714, S.426–440, doi:10.1097/gme.0b013e3181c5159c (lww.com).
Belal Naser, Jörg Schnitker, Mary Jane Minkin, Susana Garcia de Arriba, Klaus-Ulrich Nolte: Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. In: Menopause. Band18, Nr.4, April 2011, ISSN1072-3714, S.366–375, doi:10.1097/gme.0b013e3181fcb2a6 (lww.com).
Karel Rauš, Cosima Brucker, Christoph Gorkow, Wolfgang Wuttke: First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. In: Menopause. Band13, Nr.4, Juli 2006, ISSN1072-3714, S.678–691, doi:10.1097/01.gme.0000196813.34247.e2 (lww.com).
